Sign in
4

Changes in Ownership

Edgewise Therapeutics, Inc. Filed Acc 0001562180-21-005459

Options or other derivatives

  • Chief Financial Officer acquired 120,000 shares (grant or award)

From the SEC's structured data for this filing

Trades in this filing

Table II: Derivative

Insider Date Transaction Shares Price Value Exercise Expires Underlying Owned after D/I
Carruthers R Michael Chief Financial Officer 2021-08-17 Grant or award · Stock Option (Right to Buy) +120,000 120,000 D: show line 1 in the form
Loading xslF345X03/primarydocument.xml…